Alan Towne, MD
Neurology · Richmond, VANPI 1194744714
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $22,635 of the $27,368 with a category attached, or 82.7%. AbbVie accounts for 85.9% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2020 at $17,786 and has fallen 98.5% since, to $259 in 2025.
Across 158 payments — averaging $173.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$24K
- Biohaven Pharmaceuticals, Inc.$2K
- UCB, Inc.$1K
- SK Life Science, Inc.$586
- Livanova USA, Inc.$156
- Zimmer Biomet$36
- plus $128 from 5 others
Across 17 payments — averaging $2619.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$45K
What the payments were for
- Speaking & faculty fees$22,63583%
- Travel & lodging$8003%
- Food & beverage$3,65813%
- Education$2751%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 97 | $23,508 |
| Biohaven Pharmaceuticals, Inc. | 3 | $1,679 |
| UCB, Inc. | 40 | $1,276 |
| SK Life Science, Inc. | 8 | $586 |
| Livanova USA, Inc. | 4 | $156 |
| Zimmer Biomet | 1 | $36 |
| Monteris Medical Corporation | 1 | $34 |
| Neuropace, Inc. | 1 | $34 |
| Johnson & Johnson | 1 | $26 |
| Electronic Waveform Lab, Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$21,956
- NURTEC ODT$1,625
- QULIPTA$122
- XCOPRI$106
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$103
How this compares
$27,368 in reported general payments places this provider in the 85th percentile of 474 neurology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Richmond
- Catherine HamRichmond$603K
- Daniel HardyRichmond$382K
- Myla GoldmanRichmond$132K
- Alan SchulmanRichmond$104K
- Warren FeltonRichmond$96K
- John WittmanRichmond$61K
- Matthew BoyceRichmond$56K
- Leslie CloudRichmond$46K
- Jonathan BekensteinRichmond$37K
- Jessica LehositRichmond$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.